Variation in plant Toll/Interleukin-1 receptor domain protein dependence on ENHANCED DISEASE SUSCEPTIBILITY 1

被引:22
|
作者
Johanndrees, Oliver [1 ]
Baggs, Erin L. [2 ,3 ]
Uhlmann, Charles [1 ]
Locci, Federica [1 ]
Laessle, Henriette L. [1 ]
Melkonian, Katharina [1 ]
Kaeufer, Kiara [1 ]
Dongus, Joram A. [1 ]
Nakagami, Hirofumi [1 ]
Krasileva, Ksenia, V [2 ,3 ]
Parker, Jane E. [1 ,4 ]
Lapin, Dmitry [1 ,5 ]
机构
[1] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Cologne, Germany
[2] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA
[3] Earlham Inst, Norwich Res Pk, Norwich, Norfolk, England
[4] Cluster Excellence Plant Sci CEPLAS, Dusseldorf, Germany
[5] Univ Utrecht, Dept Biol Translat Plant Biol, Utrecht, Netherlands
基金
欧洲研究理事会; 英国生物技术与生命科学研究理事会;
关键词
NAD(+) CLEAVAGE ACTIVITY; CELL-DEATH; TIR DOMAINS; RESISTANCE PROTEIN; PATHOGEN EFFECTOR; SELF-ASSOCIATION; STRUCTURAL BASIS; EVOLUTION; DEFENSE; FAMILY;
D O I
10.1093/plphys/kiac480
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Plant Toll/Interleukin-1 receptor domain proteins can use different mechanisms to induce cell death. Toll/Interleukin-1 receptor (TIR) domains are integral to immune systems across all kingdoms. In plants, TIRs are present in nucleotide-binding leucine-rich repeat (NLR) immune receptors, NLR-like, and TIR-only proteins. Although TIR-NLR and TIR signaling in plants require the ENHANCED DISEASE SUSCEPTIBILITY 1 (EDS1) protein family, TIRs persist in species that have no EDS1 members. To assess whether particular TIR groups evolved with EDS1, we searched for TIR-EDS1 co-occurrence patterns. Using a large-scale phylogenetic analysis of TIR domains from 39 algal and land plant species, we identified 4 TIR families that are shared by several plant orders. One group occurred in TIR-NLRs of eudicots and another in TIR-NLRs across eudicots and magnoliids. Two further groups were more widespread. A conserved TIR-only group co-occurred with EDS1 and members of this group elicit EDS1-dependent cell death. In contrast, a maize (Zea mays) representative of TIR proteins with tetratricopeptide repeats was also present in species without EDS1 and induced EDS1-independent cell death. Our data provide a phylogeny-based plant TIR classification and identify TIRs that appear to have evolved with and are dependent on EDS1, while others have EDS1-independent activity.
引用
收藏
页码:626 / 642
页数:17
相关论文
共 50 条
  • [41] Genetic variation of the interleukin-1 family and nongenetic factors determining the interleukin-1 receptor antagonist phenotypes
    Luotola, Kari
    Pietila, Arto
    Alanne, Mervi
    Lanki, Timo
    Loo, Britt-Marie
    Jula, Antti
    Perola, Markus
    Peters, Annette
    Zeller, Tanja
    Blankenberg, Stefan
    Salomaa, Veikko
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2010, 59 (10): : 1520 - 1527
  • [42] Contribution of Interleukin-1 Receptor Accessory Protein b to Interleukin-1 Actions in Neuronal Cells
    Nguyen, L.
    Rothwell, N. J.
    Pinteaux, E.
    Boutin, H.
    NEUROSIGNALS, 2011, 19 (04) : 222 - 230
  • [43] A polymorphism in Toll-interleukin 1 receptor domain containing adaptor protein is associated with susceptibility to meningeal tuberculosis - Reply to Muula
    Laufer, Miriam K.
    Thesing, Phillip C.
    Plowe, Christopher V.
    van Oosterhout, Joep J. G.
    Ziljstra, Edward E.
    Taylor, Terrie E.
    JOURNAL OF INFECTIOUS DISEASES, 2006, 194 (08): : 1188 - 1189
  • [44] Interleukin-1α, interleukin-1β and interleukin-1 receptor antagonist share a common U-shaped recognition epitope on interleukin-1 receptor surface
    Ma, Huaijun
    Liu, Jie
    Wu, Wei
    He, Ping
    JOURNAL OF MOLECULAR RECOGNITION, 2022, 35 (09)
  • [45] THE INTERLEUKIN-1 RECEPTOR
    DINARELLO, CA
    CLARK, BD
    PUREN, AJ
    SAVAGE, N
    ROSOFF, PM
    IMMUNOLOGY TODAY, 1989, 10 (02): : 49 - 51
  • [46] THE INTERLEUKIN-1 RECEPTOR
    DOWER, SK
    URDAL, DL
    IMMUNOLOGY TODAY, 1987, 8 (02): : 46 - 51
  • [47] Mucosal imbalance of interleukin-1β and interleukin-1 receptor antagonist in canine inflammatory bowel disease
    Maeda, Shingo
    Ohno, Koichi
    Nakamura, Kenji
    Uchida, Kazuyuki
    Nakashima, Ko
    Fukushima, Kenjiro
    Tsukamoto, Atsushi
    Goto-Koshino, Yuko
    Fujino, Yasuhito
    Tsujimoto, Hajime
    VETERINARY JOURNAL, 2012, 194 (01): : 66 - 70
  • [48] INTERLEUKIN-1 RECEPTOR ANTAGONIST COMPETITIVELY INHIBITS THE BINDING OF INTERLEUKIN-1 TO THE TYPE-II INTERLEUKIN-1 RECEPTOR
    GRANOWITZ, EV
    CLARK, BD
    MANCILLA, J
    DINARELLO, CA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (22) : 14147 - 14150
  • [49] THE INHIBITORY ACTIVITY OF HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IS ENHANCED BY TYPE-II INTERLEUKIN-1 SOLUBLE RECEPTOR AND HINDERED BY TYPE-I INTERLEUKIN-1 SOLUBLE RECEPTOR
    BURGER, D
    CHICHEPORTICHE, R
    GIRI, JG
    DAYER, JM
    JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01): : 38 - 41
  • [50] INTERLEUKIN-1 AND THE INTERLEUKIN-1 RECEPTOR - STRATEGIES FOR DRUG DISCOVERY
    GAGE, LP
    BENJAMIN, WR
    CHIZZONITE, RA
    DELORENZO, W
    GUBLER, U
    MCINTYRE, KW
    STERN, AS
    UNOWSKY, J
    LOMEDICO, PT
    KILIAN, PL
    THERAPEUTIC APPROACHES TO INFLAMMATORY DISEASES, 1989, : 17 - 26